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Abstract: Despite numerous studies on women’s cardiac health throughout the past decade, the
number of female deaths caused by cardiovascular disease still rises and remains the leading cause
of death in women in most areas of the world. Novel studies have demonstrated that cardiovascular
disease, and more specifically coronary artery disease presentations in women, are different than
those in men. In addition, pathology and pathophysiology of the disease present significant
gender differences, which leads to difficulties concerning diagnosis, treatment and outcome of the
female population. The reason for this disparity is all steps for female cardiovascular disease
evaluation, treatment and prevention are not well elucidated; and an area for future research. This
review brings together the most recent studies published in the field of coronary artery disease
in women and points out new directions for future investigation on some of the important issues.
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Introduction
The first female-specific recommendations for preventive cardiology were published in
1999 (Mosca et al 1999). Even though research in the treatment of cardiovascular disease
(CVD) had advanced in many areas, it remains the leading cause of death in women in
most parts of the world. Studies have shown that 500 thousand women die of CVD every
year in the United States, somewhat near one death every minute (American Heart
Association 2003). Such index exceeds not only the number of deaths in men, but also the
next seven causes of death in women combined, and more importantly, coronary artery
disease (CAD) is believed to be the major cause responsible for these deaths (American
Heart Association 2003). Over a quarter of a million deaths per year are attributed to CAD
alone in the United States (Merz et al 2004). Although already high, these figures are
expected to rise even more during the next decades, due to an increase of diabetes and
obesity, as well as the aging of the world population (Merz et al 2004).
Even though women have a higher frequency of chest pain/angina than men, the
incidence of obstructive CAD in the female population is lower when compared with
men with similar symptoms (Kenedy et al 1982; Diamond et al 1983; Merz et al 1999). In
addition, it would appear that young women with obstructive CAD have a worse
prognosis after acute myocardial infarction (AMI), whereas older women in similar
circumstances often present with larger number of comorbidities that adversely influence
the outcome, when compared to men (Coronado et al 1997). Women with acute coronary
syndromes (ACS) are also less likely to receive rapid effective diagnosis and treatment
than are men (Ayanian and Epstein 1991; Maynard et al 1996; Pope
et al 2000).
Regarding the North American population, the Women’s Ischemic Syndrome
Evaluation (WISE) study workshop (Hayes et al 2004; Maseri 2004; Nabel et al 2004;
Pepine et al 2004; Shaw et al 2004; Waters et al 2004) from the National Heart, Lung and
Coronary artery disease in women: a review
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CASE REPORT
Emergency endovascular repair of acute 
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Background: Acute descending thoracic aortic dissection is a life-threatening emergency. It 
is not often considered as the initial diagnosis in patients presenting with epigastric pain and 
could easily be missed in a busy casualty department.
Aim: This case report is aimed to highlight the feasibility of the technique and the need for 
long-term surveillance following endovascular repair of acute thoracic aortic dissection.
Results: The patient presented with epigastric pain radiating to the interscapular region with a 
stable hemodynamic status. A computerized tomography (CT) scan demonstrated type B thoracic 
aortic dissection of the proximal descending thoracic aorta. A successful endovascular repair 
was carried out with uneventful recovery and follow-up CT scan six years after stent-grafting 
shows satisfactory position of the stent-graft, patent false lumen in the abdominal aorta perfusing 
the right kidney, and progressively enlarging diameter of the abdominal aorta.
Conclusion: Thoracic aortic dissection should be considered as a differential diagnosis in 
patients presenting with epigastric and interscapular chest pain. Emergency endovascular repair 
of acute thoracic aortic dissection is feasible and relatively safe. Regular follow-up with CT scan 
is required to evaluate the long-term efﬁ  cacy and identify the need for re-intervention.
Keywords: aortic, dissection, endovascular, thoracic
Introduction
Aortic dissection was ﬁ  rst described by the personal physician to King George II 
in 1796 (Ross 1999). Early diagnosis of aortic dissection remains a challenge and 
in 30%–40% of cases, there is a delay in the initial diagnosis (Spittel et al 1993). 
The overall mortality for acute descending thoracic aortic dissection (ADTAD) with 
conservative antihypertensive treatment is reported to be 1.6% with a sharp increase 
in mortality to 31.5% for open surgical repair (Tefera et al 2007). However, the endo-
vascular repair for emergency thoracic aortic dissection is associated with a lower 
mortality of 12% according to the data from the combined EUROSTAR and United 
Kingdom Thoracic Endograft registries (Leurs et al 2004).
Intensive antihypertensive treatment is effective in preventing early mortality after 
ADTAD (Tefera et al 2007). The current standard therapy consists of treatment with 
a β blocker, followed by a vasodilator such as nitroprusside in order to reduce the 
systemic arterial pressure and heart rate along with analgesia.
In this report, we present a case of acute thoracic aortic Stanford type B dissection, 
successfully treated with endovascular stenting, followed by a review of recent literature 
to highlight the feasibility of the technique and the need for long-term surveillance 
following endovascular repair of thoracic aortic dissection.
Case report
A 57-year-old female sociology student presented to the emergency department with 
5–6 days history of persistent epigastric pain radiating to the interscapular region. Vascular Health and Risk Management 2006:2(4) 465–475
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Association 2003). Such index exceeds not only the number of deaths in men, but also the
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Heart Association 2003). Over a quarter of a million deaths per year are attributed to CAD
alone in the United States (Merz et al 2004). Although already high, these figures are
expected to rise even more during the next decades, due to an increase of diabetes and
obesity, as well as the aging of the world population (Merz et al 2004).
Even though women have a higher frequency of chest pain/angina than men, the
incidence of obstructive CAD in the female population is lower when compared with
men with similar symptoms (Kenedy et al 1982; Diamond et al 1983; Merz et al 1999). In
addition, it would appear that young women with obstructive CAD have a worse
prognosis after acute myocardial infarction (AMI), whereas older women in similar
circumstances often present with larger number of comorbidities that adversely influence
the outcome, when compared to men (Coronado et al 1997). Women with acute coronary
syndromes (ACS) are also less likely to receive rapid effective diagnosis and treatment
than are men (Ayanian and Epstein 1991; Maynard et al 1996; Pope
et al 2000).
Regarding the North American population, the Women’s Ischemic Syndrome
Evaluation (WISE) study workshop (Hayes et al 2004; Maseri 2004; Nabel et al 2004;
Pepine et al 2004; Shaw et al 2004; Waters et al 2004) from the National Heart, Lung and
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She had past history of poorly controlled hypertension 
with no history of a collagen vascular disorder. Previously 
she had burr-hole evacuation of a traumatic acute subdural 
hematoma in 1998, with good recovery. Her hemodynamic 
parameters were stable on admission with a blood pressure 
of 145/70 mmHg in the right arm and 146/70 in the left. Air 
entry was reduced in the left lung base. Her hemoglobin was 
9.8 gm/dl with a serum creatinine of 61 mmol/L and lactate 
of 1.2 mmol/L. Both the femoral pulses were palpable and 
there was no evidence of myocardial ischemia on electro-
cardiogram. Chest radiograph showed left basal ﬂ  uid and 
an urgent computer tomography (CT) scan identiﬁ  ed a type 
B dissection of the thoracic aorta extending down to the 
abdominal aorta with an exit point of dissection in the right 
external iliac artery (EIA). Blood ﬂ  ow was seen in both the 
true and false lumens (Figure 1) with the right kidney being 
perfused by the false lumen. A decision to stent-graft the 
thoracic dissection was made in view of her persistent chest 
pain. Despite her relatively young age, the option of open 
surgical repair was not considered because of the higher 
mortality associated with surgery.
An arch angiogram showed the proximal entry tear into 
the false lumen (Figure 2). The right femoral artery was 
explored and a single thoracic stent-graft measuring 37 
mm by 15 cm (Gore Tag®, WL Gore and Associates, Inc., 
Flagstaff, Arizona, USA) was successfully deployed in the 
descending thoracic aorta to seal off the entry tear, without 
covering the ostium of the left subclavian artery (Figure 3). 
The stent-graft was oversized by 15% for the thoracic aortic 
diameter. Repeat angiogram showed that the entry tear was 
closed and the right renal artery remained patent and perfused 
by the false lumen with ﬂ  ow entering into the re-entry site 
within the right EIA. Two further stents were placed in the 
right EIA to seal off the exit site of dissection. However, the 
dissection ﬂ  ap was torn proximally into the distal abdominal 
aorta with persistent ﬂ  ow into the false lumen perfusing the 
right kidney. A decision was made to leave and monitor the 
re-entry tear with serial CT scans. The right femoral artery 
Figure 1 Computerized tomography scan showing a type B dissection of the descending thoracic aorta with true and false lumens (arrow).Vascular Health and Risk Management 2006:2(4) 465–475
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was closed and a drain was placed in the groin wound for 
three days.
Her post-operative recovery was uneventful without 
evidence of visceral, renal or spinal cord ischaemia and she 
was discharged home on the ﬁ  fth day following endovascu-
lar repair. An initial follow up CT scan at six weeks and six 
months showed satisfactory position of the thoracic and right 
external iliac stents with obliteration of the false lumen in the 
thoracic aorta and patent left subclavian artery.
She has been followed-up for six years since her thoracic 
stenting in April 2001. Her postoperative serum creatinine 
measured 64 mmol/L and has remained stable during the 
entire duration of follow-up with a recent isotope renal scan 
suggesting good bilateral renal function (Right kidney 45% 
and left kidney 55%). A recent CT scan in July 2007 shows 
that the thoracic stent-graft remains in good position. The 
false lumen is thrombosed within the thoracic aorta but 
remains patent below the level of diaphragm and is supplied 
by the true lumen through the re-entry tear perfusing the right 
kidney. Although the false lumen has slightly decreased in 
size, there is an overall increase in the diameter of infrarenal 
aorta from an initial size of 2.9 cm to 4.8 cm. At present, she 
is being closely monitored with a possibility of intervention 
for her abdominal aortic aneurysm.
Discussion
Acute dissection of descending thoracic aorta is a challenging 
emergency and most patients could be treated with intensive 
medical therapy as hypertension is the commonest predispos-
ing factor. Collagen vascular disease is a relatively uncom-
mon cause of ADTAD (Sandridge and Kern 2005). Medical 
treatment remains the mainstay of treatment in uncomplicated 
cases of ADTAD. However, at times intervention is required, 
in addition to medical treatment, to deal with the complica-
tions associated with dissection. Indications for intervention 
in ADTAD include persistent back or chest pain (as in the cur-
rent case), pseudoaneurysm 4 cm in diameter, uncontrolled 
hypertension, distal malperfusion with end organ ischemia, 
Figure 2 Arch angiogram showing the proximal entry tear into the false lumen (arrow).Vascular Health and Risk Management 2006:2(4) 465–475
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progression of dissection and rupture (Song et al 2006). Distal 
malperfusion can manifest in the form of intestinal, renal, or 
leg ischemia depending upon the vessels involved in the dis-
section process and would merit urgent intervention.
Following endovascular stenting for ADTAD the false 
lumen is thrombosed completely in the portion of the aorta 
covered by the stent-graft in over 88% of patients by the end 
of ﬁ  rst year, with 60% having thrombosed the entire length of 
dissection (Song et al 2006). Shimono and colleagues (2002) 
have reported a 58% rate of complete regression of the false 
lumen following endovascular stenting. These ﬁ  gures suggest 
that a signiﬁ  cant minority would have a patent false lumen 
as in our case, which is related to the retrograde ﬁ  lling from 
the true lumen at the site of distal tear.
The risk of spinal cord ischemia and paraplegia is low 
following endovascular stenting for thoracic aortic dissec-
tion even in patients in whom spinal segment T9–L1, which 
is usually the origin of the anterior spinal artery, had been 
covered by the endoprosthesis. Consequently, fewer spinal 
drains are required. Perioperative hypotension, length of 
aortic stents and previous or simultaneous repair of abdomi-
nal aortic aneurysm increase the risk of cord ischemia and 
paraplegia (Chiesa et al 2005).
The combined data from EUROSTAR and United King-
dom Thoracic Endograft registries report a high technical 
success rate of 88.6% for endovascular stenting in ADTAD. 
The complication rates remain low with a reported incidence 
of paraplegia and stroke at 0.8 and 1.5% respectively (Leurs 
et al 2007).  Song and colleagues (2006) has recently reported 
a 60% rate of re-intervention following endovascular stenting 
for ADTAD, the indications being proximal or junctional 
endoleaks, distal reperfusion, stent obstruction and conver-
sion to open repair. The reported 30-day mortality in most 
series is 7%–9% (Leurs et al 2004; Song et al 2006). Aortic 
fenestration is a rare procedure that is required in case of a 
distal malperfusion and end-organ ischemia (Panneton et al 
2000) as a result of enlargement of false lumen with compres-
sion of the true lumen.
Figure 3 Successful deployment of a thoracic stent in the aortic arch and proximal descending thoracic aorta, sealing off the entry tear.Vascular Health and Risk Management 2006:2(4) 465–475
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Despite its feasibility, relative safety, and encourag-
ing early results, the long-term outcome of endovascular 
approach is still under question. Although the approach 
looks simple, it does however, require the expertise of an 
experienced and dedicated endovascular team.
Conclusion
Thoracic aortic dissection should be considered as a differ-
ential diagnosis in patients presenting with acute onset of 
epigastric or interscapular pain. Emergency endovascular 
repair of acute thoracic aortic dissection is feasible and 
relatively safe. Regular follow-up with CT scan is required 
to evaluate the long-term efﬁ  cacy and identify the need for 
re-intervention.
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syndromes (ACS) are also less likely to receive rapid effective diagnosis and treatment
than are men (Ayanian and Epstein 1991; Maynard et al 1996; Pope
et al 2000).
Regarding the North American population, the Women’s Ischemic Syndrome
Evaluation (WISE) study workshop (Hayes et al 2004; Maseri 2004; Nabel et al 2004;
Pepine et al 2004; Shaw et al 2004; Waters et al 2004) from the National Heart, Lung and
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